November 20, 2016
1 min read

Endocrine Society still ‘disappointed’ in European regulations of EDCs

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The European Commission’s revised proposal of regulations to define and identify endocrine-disrupting chemicals is based on unnecessarily narrow criteria that will make it difficult to regulate these chemicals, the Endocrine Society said in a statement.

The new proposal requires high levels of scientific evidence to define EDCs, which “will make it nearly impossible for scientists to meet the unrealistically high burden of proof and protect the public from dangerous chemicals,” according to the statement.

The European Commission is suggesting only one category of EDCs, despite previous recommendations from the Endocrine Society for multiple categories based on the amount of evidence that exists to show the effects of a specific chemical, similar to the classification of carcinogens.

Previous studies have also found that failure to effectively regulate EDCs is costly with adverse health effects from EDC exposure costing more than $340 billion in the U.S.